CompletedPhase 4NCT00134745

Defining the Optimal Hormonal Replacement Therapy in Turner Syndrome

Studying Turner syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Line Cleemann
Principal Investigator
Line Cleemann, Doctor, L.Ac
Pediatric Unit, Hillerod Hospital
Intervention
estradiol(drug)
Enrollment
43 enrolled
Eligibility
10-25 years · FEMALE
Timeline
20052013

Study locations (1)

Collaborators

Novo Nordisk A/S · The County of Frederiksborg · The foundation of Kaptajnløjtnant Harald Jensen and Wife · The foundation of Mrs. Olga Bryde · The foundation of Mr. Ivan Nielsen

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00134745 on ClinicalTrials.gov

Other trials for Turner syndrome

Additional recruiting or active studies for the same condition.

See all trials for Turner syndrome

← Back to all trials